Dynamiсs of vascular stiffness parameters and central pressure on long-term antihypertensive therapy
https://doi.org/10.18705/1607-419X-2011-17-3-222-228
Abstract
Objeсtive. To assess the changes of vascular stiffness and central blood pressure in hypertensive patients on long-term antihypertensive therapy. Patients and methods. 84 subjects (56 women and 28 men) with hypertension and/or risk factors were screened. Mean age was 52,1 ± 10,6 years. Biochemistry (serum glucose and lipids), anthropometry, blood pressure (BP), arterial stiffness, central BP and ankle brachial index were assessed. Carotid ultrasound with estimation of intima-media thickness and echocardiography were performed. All patients were divided into 3 groups depending on the administered therapy: angiotensin converting enzyme (ACE) inhibitors (enalapril 5 mg, 52 subjects), beta-blockers (bisoprolol 5 mg, 22 subjects), calcium channel blockers (amlodipine 5 mg, 10 subjects). All parameters were assessed initially and after 3 and 12 months. To define age impact 2 subgroups were formed: 30-49 and 50-70 years old. Results. Arterial stiffness decreased after 3-month antihypertensive therapy, and no further changes were observed at long-term follow-up. The greatest decrease of the peripheral BP was observed in the group of ACE inhibitors, but central BP markedly decreased in calcium antagonists group. Patients over 50 years old had higher values of peripheral and central BP and subclinical target organ damage signs. Older patients showed better reversal of peripheral and central BP on antihypertensive therapy.
About the Authors
V. V. Ivanenko
Almazov Federal Heart, Blood and Endocrinology Centre, St Petersburg
Russian Federation
Russian Federation
O. P. Rotar
Almazov Federal Heart, Blood and Endocrinology Centre, St Petersburg
Russian Federation
Russian Federation
O. B. Dubrovskaya
Almazov Federal Heart, Blood and Endocrinology Centre, St Petersburg
Russian Federation
Russian Federation
E. G. Malev
Almazov Federal Heart, Blood and Endocrinology Centre, St Petersburg
Russian Federation
Russian Federation
E. A. Sokalskaya
Almazov Federal Heart, Blood and Endocrinology Centre, St Petersburg
Russian Federation
Russian Federation
A. O. Konradi
Almazov Federal Heart, Blood and Endocrinology Centre, St Petersburg
Russian Federation
Russian Federation
References
1. Nicols W. Clinical measurement of arterial stiffness obtained from noninvasive pressure waveforms // Am. Hypertension. - 2005. - Vol. 18, № 1, Pt. 2. - P. 3S-10S.
2.
3. Chen C., Nevo E. Estimation of central aortic pressure waveform by mathematical transformation of radial tonometry pressure: validation of generalized transfer function // Circulation. - 1997. - Vol. 95, № 7. - P. 1827-1836.
4.
5. Lemogoum D., Flores G.V alidity of pulse pressure and augmentation index as surrogate measures of arterial stiffness during beta-adrenergic stimulation // J. Hypertens. - 2004. - Vol. 22, № 3. - P. 511-517.
6.
7. Pannier B.M <http://www.ncbi.nlm.nih.gov/pubmed?term=%22Pannier%20BM%22%5BAuthor%5D>. Avolio A., Hoeks A., Mancia G <http://www.ncbi.nlm.nih.gov/pubmed?term=%22Mancia%20G%22%5BAuthor%5D>., Takazawa K <http://www.ncbi.nlm.nih.gov/pubmed?term=%22Takazawa%20K%22%5BAuthor%5D>. Methods and devices for measuring arterial complianсe in humans // Am. J. Hypertens. - 2002. - Vol. 15, № 8. - P. 743-753.
8.
9. Blacher J., Pannier B., Guerin A., Marchais S.J., Safar M.E., London G.M. Carotid arterial stiffness as a predictor of cardiovascular and all-cause mortality in end-stage renal disease // Hypertension. - 1998. - Vol. 32, № 3. - P. 570-574.
10.
11. Suzuki H. Use of epidemiological data to predict the occurrence of atherosclerosis disease in urban residence // Nippon Igakkai Zasshi. - 1996. - Vol. 33. - P. 360-370.
12.
13. Sesso H.D., Stampfer M.J., Rosner B. et al. Systolic and diastolic blood pressure, pulse pressure and mean arterial pressure as predictors of cardiovascular disease risk // Hypertension. - 2008. - Vol. 36, № 5. - P.801-807.
14.
15. Boutouyrie P., Busse C., Lacolley P. et al. Association between local pulse pressure, mean blood pressure and large artery remodeling // Circulation. -2009. - Vol. 100. - P. 1387-1393.
16.
17. Asmar R. Arterial stiffness and pulse wave veloсity // Clin. Appl. - 2000. - Vol. 103. - P. 1387-1393.
18.
19. Dijk J.M., Algra A., van der Graaf Y., Grobbee D.E., Bots M.L.; SMART study group. Carotid stiffness and risk of new vascular events in patients with manifest cardiovascular disease; The Smart Study // Eur. Heart J. - 2005. - Vol. 26, № 12. - P. 1213-1220.
20.
21. Lakatta E., Levy D. Arterial and cardiac ageing: major sharholders in cardiovascular disease enterprises. Part 1: ageing arteries a «set up» for vascular disease // Circulation. - 2003. - Vol. 107, № 2. - P. 139-146.
22.
23. Asmar J., Ruidavets J.B., Charmontin B. et al. Arterial stiffness and cardiovascular risk factors in a population-based study // J. Hypertens. - 2001. - Vol. 19, № 3. - P. 381-387.
24.
25. Guidelines for the management of arterial hypertension/The Task Force for the Management of Arterial Hypertension of the European Society of Cardiology (ESC) // J. Hypertens. - 2007. - Vol. 25, № 6. - P. 1105-1187.
26.
27. Lacolley P., Challande P., Boumazaet S. et al. Mechanical properties and structure of arteries in mice lacking desmin // Cardiovasc. Res. - 2001. -Vol. 51, № 1. - P. 178-187.
28.
29. Stefanadis C.I. , Kyvelou S.M., Deligeorgis A.D. et al. Arterial stiffness on offspring of hypertensive patients // Int. J. Cardiol. - 2008. - Vol. 129, № 3. - P. 438-440.
30.
31. Asmar R., London G., O'Rourke M., Safar M.E.; REASON Project Coordinators and Investigators. Improvement in blood pressure, arterial stiffness and wave reflections with a very-low-dose perindopril/indapamide combination in hypertensive patients. A comparison with atenolol // Hypertension. - 2001. - Vol. 38, № 4. - P. 922-926.
32.
33. Salonen J.T., Salonen R. Ultrasound B- mode imaging in observational studies of atherosclerosis progression // Circulation. - 1993. -Vol. 87, № 3 (Suppl.). - P. 1156-1165.
34.
35. Laurent S., Boutouyrie P., Asmar R. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients // Hypertension. - 2001. - Vol. 37, № 5. - P. 1236-1241.
36.
37. Madhavan S., Ooi W.L., Cohen H., Alderman M.H. Relation of pulse pressure and blood pressure reduction to the incidence of myocardial infarction // Hypertension. - 1994. - Vol. 23, № 3. - P. 395-401.
38.
39. Hayward C.S., Avolio A.P., O'Rourke M.F. Arterial pulse wave velocity and heart rate. Effects of beta-bloсkers // Hypertension. - 2002. - Vol. 40, № 6. - P. e8-e9.
40.
41. London G.M., Blacher J., Pannier B., Guérin A.P., Marchais S.J., Safar M.E. Arterial wave reflections and survival in end-stage renal failure // Hypertension. - 2001. - Vol. 38, № 3. - P. 434-438.
42.
43. Mahmud A., Cruickshank K., Riste L., Dunn G. Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance // J. Circulation. - 2002. - Vol. 106. - P. 2085-2090.
44.
45. Laurent S. Аrterial wall hypertrophy and stiffness in essential hypertensive patients // Hypertension. - 1995. - Vol. 26, № 2. - P. 1236-1241.
46.
47. The CAFE Investigators, for the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) Investigators. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes. Principal results of the Conduit Artery Function Evaluation (CAFE) Study // Circulation. - 2006. - Vol. 113, № 9. - P. - 1213-1225.
48.
49. Dahlof B., Sever P.S., Poulter N.R., for the ASCOT investigators. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial // Lancet. - 2005. - Vol. 366, № 9489. - P. 895-906.
50.
51. Hansen T.W., Staessen J., Torp-Pederson C. et al. Prognostic value of aortic pulse wave velocity as index of arterial stiffness in general population // Circulation. - 2006. - Vol. 113, № 5. - P. 664-670.
52.
53. Laurent S., Kingwell B., Bank A., Weber M <http://www.ncbi.nlm.nih.gov/pubmed?term=%22Weber%20M%22%5BAuthor%5D>., Struijker-Boudier H <http://www.ncbi.nlm.nih.gov/pubmed?term=%22Struijker-Boudier%20H%22%5BAuthor%5D>. Clinical applications of arterial stiffness: therapeutics and pharmacology // Am. J. Hypertens. - 2002. - Vol. 15, № 5. - P. 453-458.
54.
55. London G.M., Sсhmeider R., Calvo C., Asmar R. On behalf of the X-CELLENT study investgators. Indapamide SR versus candesartan and amlodipine in hypertension: the X-CELLENT study // Am J. Hypertens. - 2006. - Vol. 19, № 1. - P. 113-121.
56.
57. Failia М., Safar M.E., Orourke M.F. Arterial stiffness in hypertension // Handbook of hypertension. - Elsevier, 2006. - 598 p.
58.
59. Конради А.О., Захаров Д.В., Рудоманов О.Г., Зуева И.Б. Структурно-функциональное состояние миокарда у больных гипертонической болезнью при терапии коринфаром-ретард // В сб.: Актуальные вопросы современной эхокардиографии. - СПб.: Изд-во СПбГМУ, 1996. - С. 123-127.
60.
61. DuBois D., DuBois E.F. A formula to estimate the approximate surface area if height and weight be known // Arch. Int. Med. - 1916. - Vol. 17. - P. 863-871.
62.
63. Lang R.M., Bierig M., Devereux R.B. Recommendations for chamber quantification: a report from the American Society of Echocardiography Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology // J. Am.Soc. Echocardiogr. - 2005. - Vol. 18, № 12. - P. 1440-1463.
64.
65. Милягин В.А., Комиссаров В.Б. Современные методы определения жесткости сосудов // Артериальная гипертензия. - 2010. - Т. 16, № 2. - С. 134-143.
Review
For citations:
Ivanenko V.V., Rotar O.P., Dubrovskaya O.B., Malev E.G., Sokalskaya E.A., Konradi A.O. Dynamiсs of vascular stiffness parameters and central pressure on long-term antihypertensive therapy. "Arterial’naya Gipertenziya" ("Arterial Hypertension"). 2011;17(3):222-228. (In Russ.) https://doi.org/10.18705/1607-419X-2011-17-3-222-228
Views:
592
Email this article 